{"object": "trace", "id": "trace_dcb0223ca4c1487cb0f4066854f67a49", "workflow_name": "Agent workflow", "group_id": null, "metadata": null}
{"object": "trace.span", "id": "span_b26e16bce92f4066845c939c", "trace_id": "trace_dcb0223ca4c1487cb0f4066854f67a49", "parent_id": "span_7913f6d28b704ee5a66af532", "started_at": "2025-04-14T15:25:12.270391+00:00", "ended_at": "2025-04-14T15:25:14.371144+00:00", "span_data": {"type": "generation", "input": [{"content": "You are an expert rheumatology ontology coordinator responsible for analyzing knowledge graph subgraphs and orchestrating a team of specialized research agents to enrich them with contextual information. Your expertise lies in determining which information sources will be most valuable for each entity and relationship in the subgraph, then delegating searches to the most appropriate specialized agents.\n\n## ORCHESTRATION STRATEGY\n\nWhen analyzing a subgraph, follow this process:\n\n1. Initial Assessment:\n   - Carefully analyze the subgraph to identify all key entities and relationships\n   - Categorize entities by type: genes, proteins, pathways, diseases, drugs, etc.\n   - Identify relationships requiring additional context or mechanistic explanation\n   - Prioritize which elements would benefit most from enrichment\n\n2. Strategic Delegation:\n   - For each high-priority entity or relationship, determine the optimal information source:\n     * For established molecular mechanisms \u2192 Transfer to PubMed Agent\n     * For cutting-edge research \u2192 Transfer to BioRxiv Agent\n     * For comprehensive literature collection \u2192 Transfer to Europe PMC Agent\n     * For citation-rich, influential papers \u2192 Transfer to Semantic Scholar Agent\n     * For multi-source literature scans \u2192 Transfer to Firecrawl Agent\n     * For existing knowledge graph connections \u2192 Transfer to Hetionet Agent\n\n3. Contextual Query Construction:\n   - When transferring to each agent, provide context-rich guidance:\n     * Specify exactly what information you need about the entity/relationship\n     * Provide relevant context from the subgraph that might inform the search\n     * Explain how this information will help enrich the knowledge graph\n     * Set expectations for the type of relationships to focus on\n\n4. Multi-perspective Integration:\n   - After receiving information from specialist agents, integrate their findings:\n     * Reconcile potentially contradictory information\n     * Identify complementary information across different sources\n     * Recognize emergent patterns not visible in any single source\n     * Synthesize a coherent understanding of mechanisms and relationships\n\n## HANDOFF OPTIMIZATION\n\nUse each specialized agent strategically based on their unique strengths:\n\n1. PubMed Agent (peer-reviewed literature expert):\n   - Use for: Established mechanisms, validated pathways, clinical correlations\n   - Best when: Seeking high-quality evidence from peer-reviewed sources\n   - Example handoff: \"Search for validated molecular interactions between TNF-alpha and IL-6 signaling in rheumatoid arthritis synovium, focusing on mechanisms supported by multiple studies.\"\n\n2. BioRxiv Agent (preprint specialist):\n   - Use for: Emerging concepts, cutting-edge methods, newest discoveries\n   - Best when: Established literature is limited or potentially outdated\n   - Example handoff: \"Find the latest preprints on JAK-STAT inhibition in systemic lupus erythematosus, particularly novel mechanisms or targets not yet in peer-reviewed literature.\"\n\n3. Europe PMC Agent (comprehensive literature database):\n   - Use for: Broad coverage across journals, open access content, systematic reviews\n   - Best when: Need comprehensive literature analysis on a specific concept\n   - Example handoff: \"Search for comprehensive reviews and primary research on the role of ACPA in bone erosion mechanisms in rheumatoid arthritis.\"\n\n4. Semantic Scholar Agent (citation network specialist):\n   - Use for: Highly influential papers, research impact assessment, interdisciplinary connections\n   - Best when: Need to identify seminal papers or cross-disciplinary insights\n   - Example handoff: \"Find the most highly-cited papers connecting microbiome dysbiosis to autoantibody production in rheumatic diseases, focusing on mechanistic studies.\"\n\n5. Firecrawl Agent (multi-source research tool):\n   - Use for: Broad searches across multiple scientific domains, clinical guidelines\n   - Best when: Topic spans multiple disciplines or resources\n   - Example handoff: \"Search across clinical and basic science resources for evidence connecting environmental triggers to flares in psoriatic arthritis, including both molecular mechanisms and clinical observations.\"\n\n6. Hetionet Agent (knowledge graph specialist):\n   - Use for: Discovering existing network connections, biological pathways, gene-disease associations\n   - Best when: Need to establish known relationships between entities\n   - Example handoff: \"Find all connections between HLA-B27 and inflammatory pathways relevant to axial spondyloarthritis in the existing knowledge graph.\"\n\n## SYNTHESIS APPROACH\n\nAfter collecting information from specialized agents:\n\n1. Create Unstructured Sources (3-5):\n   - Synthesize the most valuable information from all agent responses\n   - Extract clear mechanistic relationships and causal pathways\n   - Include quantitative data supporting key relationships\n   - Organize information to highlight connections between subgraph entities\n   - Maintain proper attribution to original sources\n\n2. Generate Knowledge Graphs (1-2):\n   - Construct coherent extensions to the original subgraph\n   - Focus on mechanistic connections with clear directionality\n   - Include properties that provide clinical and biological context\n   - Ensure nodes and edges are precisely defined with relationship types\n   - Connect new elements logically to the original subgraph entities\n\n## RHEUMATOLOGY DOMAIN FOCUS\n\nPrioritize enrichment related to these key areas:\n- Autoimmune mechanisms (T-cell, B-cell, innate immunity pathways)\n- Inflammatory cascades and cytokine networks\n- Genetic risk factors and their functional consequences\n- Tissue-specific disease manifestations and mechanisms\n- Therapeutic targets and response biomarkers\n- Disease subtypes and precision medicine approaches\n\nYour goal is to produce a comprehensive, mechanistically detailed enrichment of the original subgraph by intelligently orchestrating specialized research agents and synthesizing their findings into a coherent knowledge representation.\n\n## SEARCH AND INFORMATION GATHERING PROTOCOL\n\nWhen your analysis requires external information (e.g., checking novelty, verifying claims, finding supporting/contradicting evidence, exploring alternative mechanisms):\n\n1.  **Assess Information Need:** Clearly define the specific information you are looking for.\n2.  **Evaluate Confidence:** Honestly assess your confidence in your current knowledge regarding the specific information needed. Are you certain about the answer or the best way to find it?\n3.  **Utilize Available Tools/Handoffs:**\n    * If you are **uncertain**, lack specific domain knowledge for the query, require information from a specialized source (like preprints, specific databases, or existing knowledge graphs), or believe a more focused search is necessary, you **MUST** utilize the appropriate tools or handoff agents provided to you (refer to your configured `tools` and `handoffs`).\n    * Do **not** attempt to answer from memory or general knowledge if external verification or specialized search is warranted and available resources exist.\n    * Formulate precise queries or instructions for the tool/agent you are calling. Provide necessary context from your current task.\n4.  **Synthesize Results:** Integrate the information obtained from tools/handoffs back into your primary analysis. Your core responsibility is [mention agent's main function, e.g., 'critical assessment', 'evidence verification', 'hypothesis refinement'], rely on specialized resources for information retrieval when appropriate.\n\n", "role": "system"}, {"role": "user", "content": "\n    # ONTOLOGY ENRICHMENT TASK - MANDATORY EXTERNAL VALIDATION\n\n## MANDATE\nYou are an expert rheumatology ontology coordinator. Your primary goal in this task is **NOT** just to analyze the provided subgraph, but to **actively enrich and validate it using external, current information obtained via mandatory handoffs to your specialized research agents.** You MUST NOT rely solely on the information present in the initial subgraph or your internal knowledge base for generating the enrichment output.\n\n## SUBGRAPH TO ANALYZE\nThe following knowledge graph subgraph represents relationships between biomedical entities in rheumatology:\n\n<subgraph>\n{\n  \"subgraph_id\": \"6ab55273358273b07813aed177dc9ce022dbfcf754c166f2c27a62be81429c6f\",\n  \"graph_data\": {\n    \"nodes\": [\n      {\n        \"sources\": [\n          {\n            \"relation\": \"influenced by genetic variations in\",\n            \"triplet_id\": 2371555718016\n          },\n          {\n            \"relation\": \"expression regulated by\",\n            \"triplet_id\": 2371555718976\n          },\n          {\n            \"relation\": \"influence expression of\",\n            \"triplet_id\": 2371555719360\n          },\n          {\n            \"relation\": \"expression also modulated by\",\n            \"triplet_id\": 2371555717872\n          }\n        ],\n        \"node_name\": \"IL17A and IL17F genes\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"can be influenced by the activity of\",\n            \"triplet_id\": 2371555720512\n          },\n          {\n            \"relation\": \"target specific\",\n            \"triplet_id\": 2371555717488\n          },\n          {\n            \"relation\": \"can be downregulated by modulation of\",\n            \"triplet_id\": 2371555716720\n          },\n          {\n            \"relation\": \"alter cytokine signaling pathways involved in\",\n            \"triplet_id\": 2371555720368\n          }\n        ],\n        \"node_name\": \"microRNAs (miRNAs) associated with immune response regulation\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"shown to modulate\",\n            \"triplet_id\": 2371554945760\n          },\n          {\n            \"relation\": \"influenced by genetic variations in\",\n            \"triplet_id\": 2371555718016\n          },\n          {\n            \"relation\": \"alter cytokine signaling pathways involved in\",\n            \"triplet_id\": 2371555720368\n          },\n          {\n            \"relation\": \"activation elevated by\",\n            \"triplet_id\": 2371555716624\n          }\n        ],\n        \"node_name\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"target specific\",\n            \"triplet_id\": 2371555717488\n          },\n          {\n            \"relation\": \"interact with\",\n            \"triplet_id\": 2371555716768\n          },\n          {\n            \"relation\": \"regulate genes activated in\",\n            \"triplet_id\": 2371555716576\n          },\n          {\n            \"relation\": \"influence outcomes of\",\n            \"triplet_id\": 2371555716672\n          }\n        ],\n        \"node_name\": \"transcription factors involved in immune cell differentiation\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"interact with\",\n            \"triplet_id\": 2371555716768\n          },\n          {\n            \"relation\": \"modulated by oxidative stress through the activation of\",\n            \"triplet_id\": 2371555716480\n          },\n          {\n            \"relation\": \"influence expression of\",\n            \"triplet_id\": 2371555719360\n          },\n          {\n            \"relation\": \"expression also modulated by\",\n            \"triplet_id\": 2371555717872\n          }\n        ],\n        \"node_name\": \"cytokine signaling pathways crucial for rheumatologic conditions\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"modulated by oxidative stress through the activation of\",\n            \"triplet_id\": 2371555716480\n          },\n          {\n            \"relation\": \"affect activation of\",\n            \"triplet_id\": 2371555718640\n          },\n          {\n            \"relation\": \"can be downregulated by modulation of\",\n            \"triplet_id\": 2371555716720\n          },\n          {\n            \"relation\": \"regulate genes activated in\",\n            \"triplet_id\": 2371555716576\n          },\n          {\n            \"relation\": \"may affect efficacy of\",\n            \"triplet_id\": 2371555708800\n          }\n        ],\n        \"node_name\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"shown to modulate\",\n            \"triplet_id\": 2371554945760\n          },\n          {\n            \"relation\": \"may affect efficacy of\",\n            \"triplet_id\": 2371555708800\n          },\n          {\n            \"relation\": \"interact with compounds used in\",\n            \"triplet_id\": 2371555716864\n          },\n          {\n            \"relation\": \"influence outcomes of\",\n            \"triplet_id\": 2371555716672\n          }\n        ],\n        \"node_name\": \"Novel Therapeutic Approaches\"\n      },\n      {\n        \"sources\": [\n          {\n            \"relation\": \"expression regulated by\",\n            \"triplet_id\": 2371555718976\n          },\n          {\n            \"relation\": \"can be influenced by the activity of\",\n            \"triplet_id\": 2371555720512\n          },\n          {\n            \"relation\": \"affect activation of\",\n            \"triplet_id\": 2371555718640\n          },\n          {\n            \"relation\": \"interact with compounds used in\",\n            \"triplet_id\": 2371555716864\n          },\n          {\n            \"relation\": \"activation elevated by\",\n            \"triplet_id\": 2371555716624\n          }\n        ],\n        \"node_name\": \"epigenetic modifications impacting histone acetylation\"\n      }\n    ],\n    \"edges\": [\n      {\n        \"source\": \"IL17A and IL17F genes\",\n        \"target\": \"epigenetic modifications impacting histone acetylation\",\n        \"relation\": \"expression regulated by\",\n        \"sources\": [\n          {\n            \"relation\": \"expression regulated by\",\n            \"triplet_id\": 2371555718976\n          }\n        ]\n      },\n      {\n        \"source\": \"IL17A and IL17F genes\",\n        \"target\": \"cytokine signaling pathways crucial for rheumatologic conditions\",\n        \"relation\": \"expression also modulated by\",\n        \"sources\": [\n          {\n            \"relation\": \"expression also modulated by\",\n            \"triplet_id\": 2371555717872\n          }\n        ]\n      },\n      {\n        \"source\": \"microRNAs (miRNAs) associated with immune response regulation\",\n        \"target\": \"transcription factors involved in immune cell differentiation\",\n        \"relation\": \"target specific\",\n        \"sources\": [\n          {\n            \"relation\": \"target specific\",\n            \"triplet_id\": 2371555717488\n          }\n        ]\n      },\n      {\n        \"source\": \"microRNAs (miRNAs) associated with immune response regulation\",\n        \"target\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n        \"relation\": \"alter cytokine signaling pathways involved in\",\n        \"sources\": [\n          {\n            \"relation\": \"alter cytokine signaling pathways involved in\",\n            \"triplet_id\": 2371555720368\n          }\n        ]\n      },\n      {\n        \"source\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n        \"target\": \"IL17A and IL17F genes\",\n        \"relation\": \"influenced by genetic variations in\",\n        \"sources\": [\n          {\n            \"relation\": \"influenced by genetic variations in\",\n            \"triplet_id\": 2371555718016\n          }\n        ]\n      },\n      {\n        \"source\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n        \"target\": \"epigenetic modifications impacting histone acetylation\",\n        \"relation\": \"activation elevated by\",\n        \"sources\": [\n          {\n            \"relation\": \"activation elevated by\",\n            \"triplet_id\": 2371555716624\n          }\n        ]\n      },\n      {\n        \"source\": \"transcription factors involved in immune cell differentiation\",\n        \"target\": \"cytokine signaling pathways crucial for rheumatologic conditions\",\n        \"relation\": \"interact with\",\n        \"sources\": [\n          {\n            \"relation\": \"interact with\",\n            \"triplet_id\": 2371555716768\n          }\n        ]\n      },\n      {\n        \"source\": \"transcription factors involved in immune cell differentiation\",\n        \"target\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n        \"relation\": \"regulate genes activated in\",\n        \"sources\": [\n          {\n            \"relation\": \"regulate genes activated in\",\n            \"triplet_id\": 2371555716576\n          }\n        ]\n      },\n      {\n        \"source\": \"transcription factors involved in immune cell differentiation\",\n        \"target\": \"Novel Therapeutic Approaches\",\n        \"relation\": \"influence outcomes of\",\n        \"sources\": [\n          {\n            \"relation\": \"influence outcomes of\",\n            \"triplet_id\": 2371555716672\n          }\n        ]\n      },\n      {\n        \"source\": \"cytokine signaling pathways crucial for rheumatologic conditions\",\n        \"target\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n        \"relation\": \"modulated by oxidative stress through the activation of\",\n        \"sources\": [\n          {\n            \"relation\": \"modulated by oxidative stress through the activation of\",\n            \"triplet_id\": 2371555716480\n          }\n        ]\n      },\n      {\n        \"source\": \"cytokine signaling pathways crucial for rheumatologic conditions\",\n        \"target\": \"IL17A and IL17F genes\",\n        \"relation\": \"influence expression of\",\n        \"sources\": [\n          {\n            \"relation\": \"influence expression of\",\n            \"triplet_id\": 2371555719360\n          }\n        ]\n      },\n      {\n        \"source\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n        \"target\": \"microRNAs (miRNAs) associated with immune response regulation\",\n        \"relation\": \"can be downregulated by modulation of\",\n        \"sources\": [\n          {\n            \"relation\": \"can be downregulated by modulation of\",\n            \"triplet_id\": 2371555716720\n          }\n        ]\n      },\n      {\n        \"source\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n        \"target\": \"Novel Therapeutic Approaches\",\n        \"relation\": \"may affect efficacy of\",\n        \"sources\": [\n          {\n            \"relation\": \"may affect efficacy of\",\n            \"triplet_id\": 2371555708800\n          }\n        ]\n      },\n      {\n        \"source\": \"Novel Therapeutic Approaches\",\n        \"target\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n        \"relation\": \"shown to modulate\",\n        \"sources\": [\n          {\n            \"relation\": \"shown to modulate\",\n            \"triplet_id\": 2371554945760\n          }\n        ]\n      },\n      {\n        \"source\": \"epigenetic modifications impacting histone acetylation\",\n        \"target\": \"microRNAs (miRNAs) associated with immune response regulation\",\n        \"relation\": \"can be influenced by the activity of\",\n        \"sources\": [\n          {\n            \"relation\": \"can be influenced by the activity of\",\n            \"triplet_id\": 2371555720512\n          }\n        ]\n      },\n      {\n        \"source\": \"epigenetic modifications impacting histone acetylation\",\n        \"target\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n        \"relation\": \"affect activation of\",\n        \"sources\": [\n          {\n            \"relation\": \"affect activation of\",\n            \"triplet_id\": 2371555718640\n          }\n        ]\n      },\n      {\n        \"source\": \"epigenetic modifications impacting histone acetylation\",\n        \"target\": \"Novel Therapeutic Approaches\",\n        \"relation\": \"interact with compounds used in\",\n        \"sources\": [\n          {\n            \"relation\": \"interact with compounds used in\",\n            \"triplet_id\": 2371555716864\n          }\n        ]\n      }\n    ]\n  },\n  \"graph_stats\": {\n    \"node_count\": 8,\n    \"edge_count\": 17,\n    \"path_length\": 8\n  },\n  \"start_node\": \"Novel Therapeutic Approaches\",\n  \"end_node\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n  \"path_nodes\": [\n    \"Novel Therapeutic Approaches\",\n    \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n    \"IL17A and IL17F genes\",\n    \"epigenetic modifications impacting histone acetylation\",\n    \"microRNAs (miRNAs) associated with immune response regulation\",\n    \"transcription factors involved in immune cell differentiation\",\n    \"cytokine signaling pathways crucial for rheumatologic conditions\",\n    \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\"\n  ],\n  \"path_edges\": [\n    {\n      \"source\": \"Novel Therapeutic Approaches\",\n      \"target\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n      \"relation\": \"shown to modulate\"\n    },\n    {\n      \"source\": \"Interleukin-17 (IL-17) pathways in autoimmune disorders\",\n      \"target\": \"IL17A and IL17F genes\",\n      \"relation\": \"influenced by genetic variations in\"\n    },\n    {\n      \"source\": \"IL17A and IL17F genes\",\n      \"target\": \"epigenetic modifications impacting histone acetylation\",\n      \"relation\": \"expression regulated by\"\n    },\n    {\n      \"source\": \"epigenetic modifications impacting histone acetylation\",\n      \"target\": \"microRNAs (miRNAs) associated with immune response regulation\",\n      \"relation\": \"can be influenced by the activity of\"\n    },\n    {\n      \"source\": \"microRNAs (miRNAs) associated with immune response regulation\",\n      \"target\": \"transcription factors involved in immune cell differentiation\",\n      \"relation\": \"target specific\"\n    },\n    {\n      \"source\": \"transcription factors involved in immune cell differentiation\",\n      \"target\": \"cytokine signaling pathways crucial for rheumatologic conditions\",\n      \"relation\": \"interact with\"\n    },\n    {\n      \"source\": \"cytokine signaling pathways crucial for rheumatologic conditions\",\n      \"target\": \"NF-kB pathway, contributing to inflammation in rheumatoid arthritis\",\n      \"relation\": \"modulated by oxidative stress through the activation of\"\n    }\n  ],\n  \"context\": null,\n  \"path_score\": null,\n  \"path_score_justification\": null,\n  \"original_graph_metadata\": {\n    \"node_count\": 8,\n    \"edge_count\": 17\n  }\n}\n</subgraph>\n## RELATIONSHIP FOCUS\nStart node: Novel Therapeutic Approaches\nEnd node: NF-kB pathway, contributing to inflammation in rheumatoid arthritis\nPath nodes: Novel Therapeutic Approaches, Interleukin-17 (IL-17) pathways in autoimmune disorders, IL17A and IL17F genes, epigenetic modifications impacting histone acetylation, microRNAs (miRNAs) associated with immune response regulation, transcription factors involved in immune cell differentiation, cytokine signaling pathways crucial for rheumatologic conditions, NF-kB pathway, contributing to inflammation in rheumatoid arthritis\n"}], "output": null, "model": "o1", "model_config": {"temperature": null, "top_p": null, "frequency_penalty": null, "presence_penalty": null, "tool_choice": null, "parallel_tool_calls": null, "truncation": null, "max_tokens": null, "reasoning": null, "metadata": null, "store": null, "base_url": "https://api.openai.com/v1/"}, "usage": null}, "error": null}
{"object": "trace.span", "id": "span_7913f6d28b704ee5a66af532", "trace_id": "trace_dcb0223ca4c1487cb0f4066854f67a49", "parent_id": null, "started_at": "2025-04-14T15:25:12.269152+00:00", "ended_at": "2025-04-14T15:25:14.371265+00:00", "span_data": {"type": "agent", "name": "RheumatologyOntologyAgent", "handoffs": ["Scientific Web Search Agent", "Biorxiv Agent", "Europe PMC Agent", "Pubmed Agent", "Semantic Scholar Agent", "Hetionet Agent"], "tools": [], "output_type": "OntologyAgentOutput"}, "error": null}
